In June, the FDA had sent the company a "not approvable" letter regarding Zelnorm, saying that further studies would need to be conducted before it could be approved.

FORBES: Magazine Article

Studies like this raise interesting suggestions that need further work to examine.

BBC: Poor sleep linked to heart failure, Norwegian study says